These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 35029297)

  • 1. Response to vaccination against SARS-CoV-2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study.
    Tomowiak C; Leblond V; Laribi K; Baron M; Puppinck C; Gérard P; Courret E; Gorochov G; Sterlin D; Tournilhac O; Morel P; Cymbalista F; Roos-Weil D;
    Br J Haematol; 2022 May; 197(4):424-427. PubMed ID: 35029297
    [No Abstract]   [Full Text] [Related]  

  • 2. Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.
    Gavriatopoulou M; Terpos E; Ntanasis-Stathopoulos I; Briasoulis A; Gumeni S; Malandrakis P; Fotiou D; Migkou M; Theodorakakou F; Eleutherakis-Papaiakovou E; Kanellias N; Kastritis E; Trougakos IP; Dimopoulos MA
    Blood Adv; 2021 Nov; 5(21):4398-4405. PubMed ID: 34529762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
    Tiacci E; Mancini A; Marchetti M; D'Elia GM; Candoni A; Morotti A; Romano A; Gozzetti A; Broccoli A; De Carolis L; Bruna R; Tisi MC; Selleri C; Capponi M; Vallisa D; Cattaneo C; Della Porta MG; Busca A; Falini B; Massaia M; Bertù L; Pulsoni A; Rivela P; Corradini P; Passamonti F
    Br J Haematol; 2023 May; 201(3):411-416. PubMed ID: 36541031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
    Laribi K; Poulain S; Willems L; Merabet F; Le Calloch R; Eveillard JR; Herbaux C; Roos-Weil D; Chaoui D; Roussel X; Tricot S; Dupuis J; Dartigeas C; Bareau B; Bene MC; Baugier de Materre A; Leblond V
    Br J Haematol; 2019 Jul; 186(1):146-149. PubMed ID: 30548257
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterologous SARS-CoV-2 vaccinations in patients with B-cell lymphoid malignancies.
    Ujjani C; Greninger AL; Shadman M; Hill JA; Lynch RC; Warren EH; Gopal AK
    Am J Hematol; 2022 Feb; 97(2):E67-E69. PubMed ID: 34807468
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.
    Chan WY; Zhu C; Sanchez E; Gupta R; Fielding AK; Khwaja A; Payne EM; O'Nions J
    Br J Haematol; 2022 Aug; 198(3):478-481. PubMed ID: 35536283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of Anti-SARS CoV-2 Antibodies following Vaccination: Valuable Monitoring or Irrelevant Tool?].
    Lotz C; Herrmann J; Hübsch ME; Notz Q; Meybohm P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2022 Apr; 57(4):302-306. PubMed ID: 35451036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
    Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
    Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
    Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe and Irreversible Pancytopenia Associated With SARS-CoV-2 Bone Marrow Infection in a Patient With Waldenstrom Macroglobulinemia.
    Velier M; Priet S; Appay R; Atieh T; Lepidi H; Kaplanski G; Jarrot PA; Koubi M; Costello R; Dignat-George F; de Lamballerie X; Tichadou A; Arcani R; Couderc AL; Touati J; Varoquaux A; Berda-Haddad Y; Venton G
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e503-e505. PubMed ID: 33563581
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.
    Mravčík V; Husa P; Kumpanová Valachovičová S; Vobořil J
    Epidemiol Mikrobiol Imunol; 2022; 71(1):9-20. PubMed ID: 35477266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
    Simon D; Tascilar K; Fagni F; Krönke G; Kleyer A; Meder C; Atreya R; Leppkes M; Kremer AE; Ramming A; Pachowsky ML; Schuch F; Ronneberger M; Kleinert S; Hueber AJ; Manger K; Manger B; Berking C; Sticherling M; Neurath MF; Schett G
    Ann Rheum Dis; 2021 Oct; 80(10):1312-1316. PubMed ID: 33958324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.
    Mattiuzzi C; Lippi G
    J Infect Public Health; 2022 Apr; 15(4):395-396. PubMed ID: 35299063
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).
    Ruetalo N; Flehmig B; Schindler M; Pridzun L; Haage A; Reichenbächer M; Kirchner T; Kirchner T; Klingel K; Ranke MB; Normann A
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.